Background-landing
Quality of Practice
SNMMI is paving the way for delivery of efficient, effective and patient-centered nuclear medicine practice. This means communicating best practices to all stakeholders, from the nuclear medicine community to referring physicians to policymakers and industry. For each diagnostic and therapeutic procedure, the society is taking concrete steps to ensure high-quality, state-of-the-art care.
Bone Scintigraphy in Prostate and Breast Cancer, Ventilation/Perfusion (V/Q) Imaging in Pulmonary Embolism, Hepatobiliary Scintigraphy in Abdominal Pain, FDG PET/CT Restaging and Response Assessment of Malignant Disease, and Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Developed five new AUC in 2017.
Gastrointestinal transit, infection imaging, PET myocardial perfusion imaging, prostate cancer imaging, evaluation and treatment of differentiated thyroid cancer, renal imaging, radium-223, lymphoscintigraphy, brain imaging with HMPAO and DaT, and imaging and therapy of benign thyroid tumors.
Developing ten additional AUC.
SNMMI AUC Factsheet for Bone Scintigraphy
New SNMMI Appropriate Use Criteria (AUC) for Bone Scintigraphy in Prostate Cancer Fact Sheet
SNMMI is partnering with more than thirty organizations to collaboratively develop AUC and update existing procedure standards. In addition, new topics are being identified to expand the coverage of imaging and therapy procedures, including 18F-fluciclovine and 68Ga-DOTATATE.
Collaborating on guidelines.
SNMMI has contracts with NDSC and Stanson Health and is working with them and other CDSM vendors to ensure proper implementation of AUC and their integration with electronic health records.
Working with CDSM vendors.
SNMMI’s Differentiated Thyroid Cancer AUC Workgroup
SNMMI is working with the ACR to develop clinical data registry modules with nuclear medicine–specific fields.
Developing clinical data registry modules.
SNMMI has begun plans for both. The new therapy accreditation program is being developed with the overall goal of standardizing radionuclide therapy approaches across medical centers and continue to align with existing accreditation programs that support the diagnosis and treatment of cancer. The new Health Services Research Center would focus on studies such as health economic outcomes research for radiopharmaceuticals.
Exploring potential for a Health Services Research Center and SNMMI accreditation of nuclear medicine therapy centers.
SNMMI LogoValue Initiative logo